LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1.90 Cr | ₹1.77 Cr | ₹8.95 Cr | ₹79 Cr | ₹8.81 Cr |
What is the latest Cash Flow from Operating Activities ratio of LYKA LABS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1.90 Cr |
| Mar2024 | ₹1.77 Cr |
| Mar2023 | ₹8.95 Cr |
| Mar2022 | ₹79 Cr |
| Mar2021 | ₹8.81 Cr |
How is Cash Flow from Operating Activities of LYKA LABS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.90 Cr | 7.11 | |
| Mar2024 | ₹1.77 Cr | -80.20 | |
| Mar2023 | ₹8.95 Cr | -88.70 | |
| Mar2022 | ₹79 Cr | 799.30 | |
| Mar2021 | ₹8.81 Cr | - | |
Compare Cash Flow from Operating Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹220.4 Cr | 0.4% | 4.6% | -48% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹442,725.0 Cr | -3.2% | 10.5% | 9.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹182,775.0 Cr | 0.8% | 9.5% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,764.0 Cr | 2% | 9.9% | 35.4% | Stock Analytics | |
| CIPLA | ₹113,007.0 Cr | -1.9% | 13.3% | -6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,098.0 Cr | -1.8% | 7.4% | 8.2% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | 0.4% |
4.6% |
-48% |
| SENSEX | 0.2% |
-4.9% |
-8.4% |
You may also like the below Video Courses